BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34193409)

  • 21. Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.
    Kim JA; Ahn D; Kim BY; Choi YJ; Shin HJ; Jang SY
    Br J Ophthalmol; 2021 Feb; 105(2):290-296. PubMed ID: 31488432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves' Orbitopathy.
    Shih SR; Liao SL; Shih CW; Wei YH; Lu TX; Chou CH; Yen EY; Chang YC; Lin CC; Chi YC; Yang WS; Tsai FC
    Ocul Immunol Inflamm; 2021 Jan; 29(1):193-202. PubMed ID: 31657648
    [No Abstract]   [Full Text] [Related]  

  • 23. Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy.
    Schrijver B; Kooiman MA; Kasteleijn E; van Holten-Neelen C; Virakul S; Paridaens D; Peeters RP; van Hagen PM; Dalm VASH; Dik WA
    Thyroid; 2019 Mar; 29(3):395-404. PubMed ID: 30724135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Effect of Guggulsterone in Primary Cultured Orbital Fibroblasts Obtained From Patients with Graves' Orbitopathy.
    Kim BR; Kim J; Lee JE; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):39. PubMed ID: 32196098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves' Orbitopathy.
    Lee CE; Choi SH; Yoon JS
    Korean J Ophthalmol; 2020 Jun; 34(3):192-202. PubMed ID: 32495527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves' Orbitopathy.
    Byeon HJ; Chae MK; Ko J; Lee EJ; Kikkawa DO; Jang SY; Yoon JS
    Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):13. PubMed ID: 37555734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenic Phenotype of Adipogenesis and Hyaluronan in Orbital Fibroblasts From Female Graves' Orbitopathy Mouse Model.
    Görtz GE; Moshkelgosha S; Jesenek C; Edelmann B; Horstmann M; Banga JP; Eckstein A; Berchner-Pfannschmidt U
    Endocrinology; 2016 Oct; 157(10):3771-3778. PubMed ID: 27552248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-Methylumbelliferone suppresses hyaluronan and adipogenesis in primary cultured orbital fibroblasts from Graves' orbitopathy.
    Yoon Y; Chae MK; Lee EJ; Yoon JS
    Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1095-1102. PubMed ID: 31900640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TMEM2 inhibits the development of Graves' orbitopathy through the JAK-STAT signaling pathway.
    Li H; Min J; Yang Y; Suo W; Wang W; Tian J; Qin Y
    J Biol Chem; 2024 Feb; 300(2):105607. PubMed ID: 38159864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptomic Profiling of Control and Thyroid-Associated Orbitopathy (TAO) Orbital Fat and TAO Orbital Fibroblasts Undergoing Adipogenesis.
    Kim DW; Taneja K; Hoang T; Santiago CP; McCulley TJ; Merbs SL; Mahoney NR; Blackshaw S; Rajaii F
    Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):24. PubMed ID: 34269815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage-Orbital Fibroblast Interaction and Hypoxia Promote Inflammation and Adipogenesis in Graves' Orbitopathy.
    Görtz GE; Philipp S; Bruderek K; Jesenek C; Horstmann M; Henning Y; Oeverhaus M; Daser A; Bechrakis NE; Eckstein A; Brandau S; Berchner-Pfannschmidt U
    Endocrinology; 2022 Dec; 164(2):. PubMed ID: 36477465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-Dependent HIF-1 Activation Impacts on Tissue Remodeling in Graves' Ophthalmopathy-Implications for Smoking.
    Görtz GE; Horstmann M; Aniol B; Reyes BD; Fandrey J; Eckstein A; Berchner-Pfannschmidt U
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4834-4842. PubMed ID: 27610652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype.
    Kuriyan AE; Woeller CF; O'Loughlin CW; Phipps RP; Feldon SE
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7370-7. PubMed ID: 24135759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves' orbitopathy.
    Cao J; Qi X; Wang N; Chen Y; Xie B; Ma C; Chen Z; Xiong W
    J Endocrinol Invest; 2023 Oct; 46(10):2005-2016. PubMed ID: 36849849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Mitochondria-Linked Fatty-Acid Uptake-Driven Adipogenesis in Graves Orbitopathy.
    Zhang L; Rai P; Miwa S; Draman MS; Rees DA; Haridas AS; Morris DS; Tee AR; Ludgate M; Turnbull DM; Dayan CM
    Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34473251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. M1-Like Macrophages Modulate Fibrosis and Inflammation of Orbital Fibroblasts in Graves' Orbitopathy: Potential Relevance to Soluble Interleukin-6 Receptor.
    Lu Y; Wang Y; Wang Y; Wu Y; Huang Y; Liu X; Zhang S; Zhong S; Li Y; Li B; Sun J; Fang S; Zhou H
    Thyroid; 2023 Mar; 33(3):338-350. PubMed ID: 36617890
    [No Abstract]   [Full Text] [Related]  

  • 37. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
    Han YE; Hwang S; Kim JH; Byun JW; Yoon JS; Lee EJ
    Thyroid; 2018 Apr; 28(4):528-536. PubMed ID: 29589999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts.
    Diao J; Chen X; Mou P; Ma X; Wei R
    Invest Ophthalmol Vis Sci; 2022 Sep; 63(10):6. PubMed ID: 36094643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves' Ophthalmopathy by Targeting Orbital Fibroblasts.
    Yang S; Wang X; Xiao W; Xu Z; Ye H; Sha X; Yang H
    Front Endocrinol (Lausanne); 2022; 13():891922. PubMed ID: 35663306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves' orbitopathy.
    Wang H; Zhu LS; Cheng JW; Cai JP; Li Y; Ma XY; Wei RL
    Graefes Arch Clin Exp Ophthalmol; 2015 Apr; 253(4):573-82. PubMed ID: 25576172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.